StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.45−0.02 (-3.25%)

Close on Nov 18, 2026Market cap $803.68KP/E –Yield –

Aptevo Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aptevo Therapeutics's market cap was $1.08M on Nov 11, 2026, against $19.05M a year earlier. Over the last 5 years it ranged from $772.87K to $33.90B, with a median of $40.36M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.08M-85.1%
2025Dec 31, 2025$7.23M-81.8%
2024Dec 31, 2024$39.72M-98.3%
2023Dec 29, 2023$2.30B-77.8%
2022Dec 30, 2022$10.39B-69.3%
2021Dec 31, 2021$33.90B-67.5%
2020Dec 31, 2020$104.23B+399.8%
2019Dec 31, 2019$20.86B+2.9%
2018Dec 31, 2018$20.27B-68.3%
2017Dec 29, 2017$63.92B+83.9%
2016Dec 30, 2016$34.76B–

More Aptevo Therapeutics figures

See a number that looks wrong?